Skip to main content
AmigoFish

Using Accelerator Mass Spectrometry in Clinical Pharmacology

From Clinical Pharmacology Podcast with Nathan Teuscher · · 38 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

This episode is an interview with Dr. Wouter Vaes, the Chief Science Officer of Peregrion. We discuss how accelerator mass spectrometry is being used in early clinical development for drug metabolism and pharmacokinetics. We discuss using this technology to support development of oncology agents, determining absolute bioavailability without IV toxicology work, and more.

Links discussed in the show:

- You can contact Wouter by email: wouter.vaes@peregrion.com

- Connect with Peregrion on LinkedIn (https://www.linkedin.com/company/peregrion/posts/?feedView=all) or their website (https://www.peregrion.com/)

- Symposium on microtracer studies (https://www.peregrion.com/symposium-microtracer-ams-for-next-gen-drug-development/)

- FDA guidance on safety testing of drug metabolites (https://www.fda.gov/media/72279/download)

- White paper on human ADME data (https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2691)

- You can connect with Nathan on LinkedIn (https://go.teuschersolutions.com/linkedin) and send me a message

- Send Nathan a message (https://go.teuschersolutions.com/contact)

- Sign up for Nathan’s newsletter (https://go.teuschersolutions.com/newsletter)

Copyright Teuscher Solutions LLC

All Rights Reserved

Back to Clinical Pharmacology Podcast with Nathan Teuscher · Report a problem